Long-acting injections to treat HIV
View More
Unitaid-funded projects develop innovative medicines, diagnostic tools and public health techniques and link them quickly, and at affordable prices, to those most in need.
Our grant projects apply the best that science has to offer to the fight against HIV and co-infections, tuberculosis and malaria in lower-resource countries.
Grant focus
To transform oral HIV treatment into a long-acting injectable
Grantees
University of Washington
Status
Current
Amount
US$ 6,962,027
Disease
HIV and Co-Infection
View More
Grant focus
Enable the scale-up of optimized second-line combination antiretroviral therapy for HIV patients who have failed first-line therapy
Grantees
University of New South Wales (Kirby Institute)
Status
Current
Amount
US$ 9,026,168
Disease
HIV and Co-Infection
View More
Grant focus
Reduce rates of mother-to-child transmission of HIV among women starting antiretroviral treatment in the third trimester of pregnancy
Grantees
University of Liverpool
Status
Current
Amount
US$ 10,924,812
Disease
HIV and Co-Infection
View More
Grant focus
Improve antiretroviral treatment for HIV-positive people in low- and middle-income countries
Grantees
Wits Reproductive Health & HIV Institute
Status
Current
Amount
US$ 22,851,279
Disease
HIV and Co-Infection
View More
Grant focus
Increase access to more tolerable HIV medicines and relevant health products
Grantees
Clinton Health Access Initiative (CHAI)
Status
Complete
Amount
US$ 70,847,904
Disease
HIV and Co-Infection
View More
Grant focus
Generate robust evidence on the clinical and economic benefits of a dolutegravir-based regimen in an African setting
Grantees
Institut Bouisson Bertrand
Status
Current
Amount
US$ 3,261,312
Disease
HIV and Co-Infection
View More